School of Public Health
Faculty of Health and Medical Sciences
Mr David Tamblyn is a Team Leader in Adelaide Health Technology Assessment (AHTA) in the School of Public Health, University of Adelaide. He has worked in the field of health technology assessment for over 10 years, and has experience evaluating pharmaceuticals, devices and medical services. He has been involved in HTA evaluations for both reimbursement and regulatory purposes, and in the development of national guidelines to inform the assessment of pharmaceuticals and medical services.
Mr Tamblyn's qualifications include a Masters of Public Health, University of Adelaide and Bachelor of Health Sciences, University of Adelaide. Mr Tamblyn is a Deputy Editor for the International Journal of Technology Assessment in Health Care (IJTAHC), a committee member of the TGA Expert Advisory Panel on breast Implant Associated Anaplastic Large Cell Lymphoma, and a committee member of the South Australian Policy Advisory Committee for Technology (SAPACT).
Year Citation 2009 Beckmann, K., Pinnock, C., Tamblyn, D., Kopsaftis, T., Stapleton, A., & Roder, D. (2009). Prostate cancer in South Australia: equitable access but later presentation. In BJU INTERNATIONAL Vol. 103 (pp. 11-12). Gold Coast, AUSTRALIA: WILEY-BLACKWELL PUBLISHING, INC.
Year Citation 2015 Vogan, A., Mitchell, A., Tamblyn, D., & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway. 2013 Moshi, M. R., Tamblyn, D., & Merlin, T. (2013). Rise of Co-dependent Technologies: Surveying Stakeholders’ about their opinion on the co-dependent technology framework and decision-making process [Poster]. Poster session presented at the meeting of SA State Population Health Conference. Adelaide, South Australia. 2013 Merlin, T. L., Ellery, B., Juneja, V., & Tamblyn, D. (2013). What’s in a name? - Mapping the different HTA products of INAHTA members. Poster session presented at the meeting of the 10th Annual Meeting Health Technology Assessment international (HTAi). Seoul, South Korea.
Report for External Bodies
Year Citation 2016 Tamblyn, D., Schubert, C., & Merlin, T. L. (2016). Guidelines for preparing a submission to the Pharmaceutical Benefits Advisory Committee, Version 5.0. Commonwealth of Australia. 2012 Morona, J. K., Newton, S., Wang, S., Tamblyn, D., Ellery, B., & Merlin, T. (2012). Genetic testing for hereditary mutations in the VHL gene that cause von Hippel-Lindau syndrome (MSAC Application number 1153,). Canberra, ACT.: Commonwealth of Australia.
NHMRC Endorsed Guidelines
Year Citation 2015 Title: National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes
Authors: Morona J, Tamblyn D, Ellery B, Merlin T
Author affiliation: A1007279-A1050252-A1068278-A1018746
Publisher: Commonwealth of Australia - Department of Health
Place of publication: Australia
Publication date: 2015
Source URL: http://t2dgr.bakeridi.edu.au/LinkClick.aspx?fileticket=H_EpLXHAX_s=&tabid=172
Record created at source: 15 April 2016
2011 Publication status: Published
Title: National evidence-based guideline: Prevention, identification and mangement of foot complications in diabetes
Authors: Fitridge R, Templeton S, Buckley E, Docter S, Morona J, Reddin E, Juneja V, Merlin T
Author affiliation: A1066006-A1066294-B1134193-B1181052-B1007279-B1200662-B1216790-B1050252-B1183605-B1068278-B1177181-B1018746
Pagination: 0 pages
Publication date: 2011
Notes: Migrated record 20140814
Record created at source: 14 August 2014
Date Institution Department Organisation Type Country 2018 - ongoing South Australian Policy Advisory Committee on Technology (SAPACT) Department for Health and Wellbeing Health services and related Australia 2018 - ongoing TGA Expert Advisory Panel, Breast Implant Associated ALCL Therapeutics Goods Administration Health services and related Australia 2017 - ongoing International Journal for Technology Assessment in Health Care Editors Scientific research United Kingdom
Date Topic Presented at Institution Country 2017 - 2017 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Evaluator Workshop Canberra AHTA, presenting at request of Australian Government Department of Health Australia 2016 - 2016 Pharmaceutical Benefits Advisory Committee (PBAC) Guidelines Review Submission Sponsor Workshop Sydney (3), Melbourne (2) AHTA, presenting at request of Australian Government Department of Health Australia
Connect With Me